Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole
2006

Combination Therapy for Coccidioidomycosis

Sample size: 1 publication Evidence: low

Author Information

Author(s): Park Dae Won, Sohn Jang Wook, Cheong Hee Jin, Kim Woo Joo, Ja Kim Min, Kim Je Hyeong, Shin Chol

Primary Institution: Korea University College of Medicine

Hypothesis

Can combination therapy with caspofungin and fluconazole effectively treat diffuse coccidioidal pneumonia in an immunocompetent patient who does not respond to amphotericin B?

Conclusion

Combination therapy with caspofungin and fluconazole may be an effective alternative treatment for diffuse coccidioidal pneumonia that does not respond to standard therapy.

Supporting Evidence

  • The patient initially did not respond to amphotericin B therapy.
  • After switching to caspofungin and fluconazole, the patient showed significant clinical improvement.
  • The patient's CF antibody titre decreased from 1:64 to undetectable levels after treatment.

Takeaway

A man with a serious lung infection got better after doctors used two medicines together instead of the usual one that wasn't working.

Methodology

The patient was treated with amphotericin B initially, followed by a combination of caspofungin and fluconazole after the initial treatment failed.

Limitations

The study is based on a single case report, limiting the generalizability of the findings.

Participant Demographics

31-year-old Korean male, immunocompetent.

Digital Object Identifier (DOI)

10.1186/1471-2334-6-26

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication